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1     Introduction 
 
1.1 Metabolic reactions - interactions with drugs and other chemicals 
 
We are in a period of a rapidly growing research-based pharmaceutical industry. The 
improvement in drug research field and modern high-throughput techniques such as 3D 
modeling of protein structures, pharmacogenomics and combinatorial chemistry result in a 
large number of new entities discovered every year
1,2
. When a new molecule is a promising 
drug candidate, its physiological properties need to be determined as a part of preclinical 
trials, the first step before extensive clinical trials
3
. Absorption, distribution, metabolism and 
excretion (ADME) are the psychological properties used for describing the way in which a 
compound disposes within an organism. Drug concentration in blood depends on its ADME 
properties which influence pharmacological activity of a compound. Almost two-thirds of 
new chemical entities will fail in development as a result of poor ADME characteristic
4
. 
While most of the properties can be predicted early in the discovery phase using in vitro 
techniques and recently developed computational (in silico) modeling
5
, the determination of 
metabolic reactions remains the most challenging task. 
 
Hepatic metabolism is the main elimination mechanism for most of the drugs and non-drug 
xenobiotics. Cytochrome P-450 monooxygenase system (CYP-450) together with conjugation 
enzymes is responsible for the elimination of more than 90% drugs cleared by the liver
6
. 
Drugs are metabolised in the human liver by different forms of CYP, such as 1A2, 2A6, 2B6, 
2C8, 2C18, 2C9, 2C19, 2D6, 2E1, 3A4 and the result is a reactive molecule further 
conjugated with endogenous molecules (for example, glutathione)
7
. In the early stage of drug 
development it is necessary to determine a metabolic profile of a new compound. The 
questions such as: How fast a molecule will be metabolised; which enzymes are involved; 
what metabolites will be formed; are there any toxic metabolites; does it have interactions 
with the existing, clinically relevant drugs, are some of the questions that need to be 
answered
8
.  
Furthermore, the existence of multiple enzyme forms ("isoforms") of CYP, the variability 
among human individuals (polymorphic enzymes), and major interspecies difference makes it 
difficult to accurately predict the metabolic pathway of a new compound.  
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Therefore, in order to get a vague idea about the metabolic pathway in vivo, a large amount of 
in vitro results is necessary.  
Apart from drugs, humans are continuously exposed to compounds such as pesticides and 
household chemicals (detergents)
9
. These environmental chemicals are widely used, not only 
in agriculture and public health, but also in individual households. While physiological effects 
of drugs are widely tested, these chemicals are largely unfamiliar and understudied
10,11
. 
Humans are exposed through food, water, public places, houses or gardens and connection to 
chemical exposure continues to strengthen despite the latest efforts to limit the individual 
exposure. A number of published studies have shown that pesticides are linked to several 
health problems such as Alzheimer's disease
12
, asthma
13
, cancer
14,15 
and many more
16
. Health 
hazards of environmental and agricultural chemicals are determined from short-term studies 
while long-term effects remain unknown or become evident after epidemiological follow-up 
studies. 
The biotransformation of xenobiotics enables higher organisms to eliminate lipophilic 
substances that might otherwise cause toxic effects by accumulating in their tissues. As well 
as drugs, they use xenobiotic-metabolizing cytochrome (CYP) enzymes as the primary site for 
phase I metabolism. As a result, a large number of interactions with clinically relevant drugs 
is possible. Similar to pharmaceutical drug research, it is important to explore the full 
metabolic profile of common environmental chemicals to get an idea about their metabolic 
pathways and possible interactions.  
Recently, metabolic profiling of these chemicals has been gaining in importance, however, 
amount of data today is very limited due to lack of the fast in vitro screening assays. 
 
1.2 Selected CYP P450 reactions 
 
Nonsteroidal anti-inflammatory drugs (NSAID) are a class of most prescribed medications 
worldwide. Since their synthesis in late 1800s, phenacetin and paracetamol have become the 
most popular non-narcotic analgesic (antipyretic) drugs. By using CYP1A2, phenacetin is 
cleared through conversion to paracetamol and this reaction is used as a marker for CYP1A2 
in vitro and in vivo reactions.  
 
In addition to phenacetin, another widely used NSAID diclofenac and its conversion to 4'-
hydroxydiclofenac has been used for the determination of the enzymatic activity of CYP2C9. 
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Other drugs metabolized by CYP2C9 include ifosfamide, warfarin, phenytoin, and 
cyclophosphamide.   
Coumarin (1, 2-benzopyrone) is a xenobiotic used in treatment of edema and inflammation of 
venous and lymphatic vessels
17
. With its metabolite, 7'-hydroxycoumarine (umbelliferone), 
coumarin is used as marker reaction for CYP2A6 enzymatic activity, especially due to 
umbelliferone’s strong fluorescence properties. 
 
These three reactions were selected for this work since they have been used as common 
marker reactions for the determination of enzymatic activity in numerous in vitro and in vivo 
assays. 
Common CYP inducers among commonly used drugs are phenobarbital, phenytoin and 
rifampin. Inhibitors of CYP enzymes are ketoconazole, diltiazem, verapamil, cyclosporine 
and many more. With the available knowledge about CYP enzymes and the use of marker 
reactions for in vitro experiments useful predictions about interactions can be made.  
 
1.3 Micro Total Analysis Systems  
 
Since its introduction in the 1990s until today, the area of "Micro Total Analysis System" 
(µTAS), also called "lab on a chip", has been growing rapidly
18
. Its development started in the 
early 1980s with progressive development of silicon microfabrication processes and 
nowadays it is considered to be one of the most promising technologies in modern 
bioanalysis. The approach combines several functional elements integrated onto a single 
microfluidic platform, followed by fast analysis and very small amounts of samples. Usually, 
the analytical process follows a well-defined procedure form sample collecting, sample 
pretreatment and a long lasting analysis with a conventional analytical instrument. The ability 
of µTAS to perform injection, separation and detection within the same device has opened 
new doors in modern analytical chemistry, medicine, pharmacy, cell biology and many more. 
Besides the low sample volumes, expensive reagents can be saved and the amount of toxic 
waste minimized. 
Microfluidic devices have gained great interest since capillary electrophoresis (CE) 
microchips were presented
19,20
. Although glass and silicon dominated the early years, 
polymers such as poly(dimethylsiloxane) (PDMS)
21
, poly(methylmethacrylate) (PMMA)
22
, 
 4 
 
glycidly ether of bisphenol A (SU-8)
23
 as substrate materials have been employed due to their 
chemical and mechanical properties, low cost and ease of fabrication.  
Undoubtedly, the integration and compactness of microfluidic devices hold great promise for 
analytical chemistry and high-speed screening of a large number of new chemical entities. 
 
1.3.1 Microchip Capillary Electrophoresis (MCE) 
 
One especially exciting use for microanalytical devices is in the analysis and separation of 
chemical and biological substances. The electrophoresis of today may be one of the main 
technique for separation of both large and small molecules. Despite a number of different 
types of electrophoresis, they all include the same principle of generating an electric field 
between two points and migration of ions through matrix in-between. Basic instrumentation is 
simple. Except for capillary, a controllable high voltage supply is needed and a detector to 
detect the components of the mixture. Capillary electrophoresis combines a family of 
techniques with different performing characteristics. These are: capillary gel electrophoresis, 
capillary zone electrophoresis, isoelectric focusing, isotachophoresis and micellar 
electrokinetic capillary chromatography. 
Capillary electrophoresis (CE) employs narrow capillaries where the electroosmotic flow 
(EOF) of buffer solutions and ionic species is a fundamental process. The EOF in 
conventional silica capillaries is generated as a result of ionization of the acidic silanol groups 
of the inside capillary wall. At high pH groups get dissociated and negatively charged, 
causing cations from the solution to build up near the surface forming an "electric double 
layer". The application of high voltage results in cations moving towards cathode, carrying 
water with them. The result is net flow in the direction of negative electrode which could be 
considered an "electric pump" of CE
24
.   
In polymer chips the origin of surface charge is different. Surface charge is a result of the 
enchanted autolysis of water with the preferential adsorption of hydroxyl ions. In that way, 
solid, hydrophobic material develops negative charge similar to silica capillary
25
.  
The properties of separation in capillary are a hybrid between traditional polyacrylamide gel 
electrophoresis (PAGE) and high performance liquid chromatography (HPLC). It has 
efficiency on the order of gas chromatography (GC) or higher, it is better for quantification, 
requires small amounts of samples and reagents, it can be easily automated and uses modern 
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detector technologies. Additionally, the ability to use higher electric fields in a capillary 
results in a separation lasting only a few minutes rather than several hours
26
.  
Capillary electrophoresis is a highly popular analytical system that can be easily integrated on 
a chip. The Microchip capillary electrophoresis (MCE) provides a number of advantages. In 
the miniaturized form, a device requires even smaller quantities of reagents and the separation 
takes 2-3 minutes. The most important aspect lays in the fact that efficiency of on-chip 
electrophoretic separations is not behind the larger counterparts, but it can also perform highly 
integrated and more complex analyses. The ultimate microchip platform can be easily 
transferred to the place where analysis is needed and can be operated with ease, which makes 
it a great improvement in a term of rapid screening of numerous new biological, 
environmental and pharmaceutical entities.  
 
1.3.2 Electrochemical detection (EC) 
 
Separation techniques (electrophoresis, chromatography) on a microchip provide many 
advantages over conventional methods. On the other hand, outcomes of size reduction will 
occur in demanding detection systems. To detect modest concentrations of samples in 
microchips, highly sensitive detectors should be constructed. Some of common detection 
methods include laser-induced fluorescence (LIF) and mass spectrometry (MS), yet the 
robustness of related instrumentation and high cost analysis are incompatible with µTAS 
concept. However, low cost, easy operation, compatibility with microfabrication, selectivity 
and high sensitivity of electrochemical detection (EC) have recently raised attention
27,28
.  
The amperometric electrochemical detection measures electrical current resulting from 
oxidation or reduction of species after applying constant voltage to the working electrode. 
After the zones of analytes are separated inside a column they pass over a planar electrode 
held at a fixed potential. The potential of a working electrode is slightly higher than analyte 
potential serving as driving force for redox reaction of the analyte. Current peak, caused by 
electron transfer, is visible on the amperometry diagram as a function of time and is directly 
related to the concentration of the compound.  
To all amperometric measurements, crucial is Faraday's law of electrolysis: 
Q = n*F*N 
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N moles of material are converted under Q number of coulombs. F is Faraday's constant 
(96500 C mol
-1
) and n number of moles of electrons gained or lost in process per mole of 
material. 
With respect to time, there is a need for another equation: 
dQ/dt = n*F*dN/dt = i 
This equation represents the measurable quantity, the current released during the redox 
process occurring on the surface of electrode. Electropherograms after analysis represent the 
detector response (current) as a function of time.  
In microchips, the electrochemical detector can be integrated at the end of the separation 
channel (end-channel detection) or inside it (in-channel detection) using microfabrication 
techniques and metals such as gold, platinum or carbon. Different modifications of electrode 
surface (coatings) can enhance the power of amperometric detectors
28
. 
Potentiometry, contact and contactless conductivity are other common detection methods 
combined with microchip electrophoresis.  
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2     Aim of the thesis 
 
Progress and development of the current analytical techniques is by far too slow to keep up 
with continuous discoveries of a large amount of new chemical entities (e.g., drugs, 
household and environmental chemicals). New, sensitive and primarily fast methods are 
needed to speed up metabolic characterization (in vitro metabolic assays), drug discovery 
processes and, in general, the screening process of different samples. 
 
In this work, portable microchip capillary electrophoresis (MCE) platform with 
electrochemical detection (EC) was developed as a system that can improve rapid analysis of 
the selected CYP P450 substrates and metabolites listed in Table 1. 
MCE-EC platform was examined as practical and easily handled device ready to compete 
with traditional analytical instruments in terms of sensitivity and speed, as well as to offer 
alternative to massive and expensive instrumentation. 
 
Table 1. List of the important CYP enzymes along with their specific substrates and 
metabolites. 
 
CYP2C9 
Diclofenac 
4-hydroxylation 
 
CYP1A2 
Phenacetin 
O-de-ethylation 
 
CYP2A6 
Coumarin 
7-hydroxylation 
 
 
 
In addition to drug metabolism assays, the feasibility of the MCE-EC approach was examined 
in determination of the dissolved drug concentration following the rapid dissolution of 
nanoparticle based drug formulations. 
 8 
 
3     Materials and methods 
 
3.1 Chemicals 
 
All chemicals used in this work are listed in Table 2.  
 
Table 2. List of chemicals with suppliers and control numbers used in the research. 
Chemical Supplier CAS 
1-octanol Sigma-Aldrich, Steinheim, Germany 111-87-5 
4-hydroxydiclofenac Toronto Chemicals, Toronto, ON n/a 
Boric acid Riedel-de Haën, Seelze, Germany 31146 
Cloroform  n/a n/a 
Coumarin Sigma-Aldrich, Steinheim, Germany 91-64-5 
Dichloromethane (DCM) n/a n/a 
Diclofenac Sigma-Aldrich, Steinheim, Germany 239-346-4 
Dimethyl sulfoxide 
(DMSO) 
Sigma-Aldrich, Steinheim, Germany 67-68-5 
Dopamine Sigma-Aldrich, Steinheim, Germany 200-445-2 (EC) 
Hydrochloric acid Riedel-de Haën, Seelze, Germany n/a 
Indomethacin Sigma-Aldrich, Steinheim, Germany n/a 
Acid 2-morpholino-
ethanesulfonic hydrate 
(MES hydrate) 
Sigma-Aldrich, Steinheim, Germany 1266615-59-1 
Methanol  n/a n/a 
MQ water, deionized  Mili-Q water purification system - 
NADPH Sigma-Aldrich, Steinheim, Germany 2646-71-1 
Paracetamol 
(Acetaminophen) 
Sigma-Aldrich, Steinheim, Germany 103-90-2 
Phenacetin Sigma-Aldrich, Steinheim, Germany n/a 
Umbelliferone Sigma-Aldrich, Steinheim, Germany 202-240-3 (EC) 
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The molecular structures and pKa values of the test compounds are listed in Table 3. 
 
Table 3. List of selected substrate and metabolite pairs with pKa values. 
SUBSTRATE METABOLITE pKa 
 
 
PHENACETIN 
 
 
PARACETAMOL 
PHENACETIN 
 
15 (-NH-) 
PARACETAMOL 
 
9.5 (-OH) 
 
 
COUMARIN 
 
 
UMBELLIFERONE 
COUMARIN 
 
no ionizable atoms 
UMBELLIFERONE 
 
7.8 (-OH) 
 
 
DICLOFENAC 
 
 
4'-OH-DICLOFENAC 
DICLOFENAC 
 
4.0 (-COOH) 
4'-OH-DICLOFENAC 
 
8.6 (-COOH) 
3.8 (-OH) 
 
 
3.2 Preparation of stock solutions and buffers 
 
Stock solutions were prepared by direct weighing of the correct amount of solid chemical 
(phenacetin, paracetamol, umbelliferone, coumarin, diclofenac, 4-hydroxydiclofenac). 
Compounds were dissolved in DMSO, solutions were protected from light and stored in 
freezer over the night. The concentration of all the compounds was 10 mM, except phenacetin 
and coumarin which were prepared in a 20 mM concentration. The run samples were diluted 
from DMSO stock solutions, except for the MCE separations of the metabolite-substrate pairs 
and LLE (liquid-liquid extraction). For that purpose stock solutions were prepared in 20 mM 
sodium borate buffer (pH 10.0) in the same way, by weighing and dissolving solids in buffer. 
Phenacetin and umbelliferone were prepared in 1 mM concentration due to poor solubility in 
water. Coumarin was prepared in 5 mM concentration and paracetamol in 10 mM 
concentration solution. All stock solutions prepared in the buffer (except paracetamol with 
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very good solubility) were mixed with Vortex machine for longer period and left for at least 
15 minutes before analysis. 
Sodium borate buffer was prepared by weighing of solid boric acid and dissolving in MQ-
water. The pH was adjusted to 10 using 2 M NaOH solution.   
MES-NaOH buffer was prepared by weighing of solid MES hydrate and dissolving in MQ-
water. The pH was adjusted to 6 using 2 M NaOH solution.  
 
3.3 Instrumentation 
 
Portable and compact analytical instrument for microfluidic and electrophoresis applications 
purchased from MicruX Technologies (Oviedo, Spain) is shown on Figure 1. The instrument 
has "HVStat" (HVSTAT2010) with LiPo battery (3300 mAh) as a high voltage (HV) supply 
with maximum voltage of  ±3000 V and a biopotentiostat for dual amperometric detection. 
Microchips are placed inside the platform (MCE-HOLDER-DC02), for easier use. Holder 
integrates the electrical contacts for detection and integrated platinum wires as HV electrodes 
which enable the use of MicruX reusable electrophoresis chips (38 x 13 mm). The system is 
controlled by MicruX Manager Software v2.1.  
 
 
Figure 1. MicruX microchip electrophoresis instrument with EC detection (A); opened 
microfluidic platform with microchip inside (B). 
 
For this research, single channel SU-8/glass microchips manufactured by MicruX (Oviedo, 
Spain) were used. 150 nm thin-film electrodes were integrated on the glass cover plate and 
placed at the end of separation channel. External dimensions of each chip are 38 x 13 x 0.75 
mm, which is the size that can fit inside platform (holder). Microchannel cross-section 
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dimensions are 20 x 50 µm (height x width) and the layout features a simple cross injection 
geometry (Figure 2). Separation channel length is 35 mm (A → B) and sample injection 
channel length is 10 mm (C → D). 
 
 
Figure 2. Schematic view of a typical microchip electrophoresis system with separation and 
injection channels. 
 
Three different detector designs were used in this research.  
SU-8-Pt001T has a thin 50 µm platinum working electrode (WE) and a 250 µm platinum 
auxiliary (AE) and reference electrode (RE).  
SU-8-Pt002T has a 100 µm width of all three platinum electrodes (WE, RE, AE). 
SU-8-Au001T has the same dimensions as in SU-8-Pt001T but with gold electrodes.  
In all three designs, the gap between individual electrodes is 100 µm. 
Extra chip design was used for separation purposes, also manufactured by MicruX 
Technologies. In custom made microchip, the separation channel length (A → B) was 
prolonged to 55 mm and detector design is the same as in SU-8-Pt001T. (Figure 3.) 
 
 
 
Figure 3. Short channel (35 mm) SU-8-Pt001T microchip (A); custom, long channel (55 mm) 
SU-8-Pt001T microchip (B). 
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3.4 MCE separations with EC detection 
 
Separations of substrates and metabolites were performed on custom made long channel 
microchips with 5.5 cm separation channel length, using conditions described in Table 4. All 
samples were prepared in 20 mM sodium borate buffer (pH 10.0), which was also used as 
running buffer.  
 
Table 4. Conditions for MCE-EC substrates / metabolites separations 
 
INJECTION (C → D) SEPARATION (A → B) 
Voltage [V/cm] Time [s] Voltage [V/cm]  Time [s] 
+ 800 6 ≈ 545 V/cm 60 
 
3.5 Sample preparation by liquid phase microextraction 
 
Liquid phase microextraction (LPME) was performed using SU-8-Pt001T chip. The chip was 
removed from the holder and filled with 20 mM sodium borate buffer (pH 10.0) (acceptor 
solution) using vacuum suction. On sample inlet “C” one more drop was added to decrease 
the possibility of air bubble retention under membrane. A small piece (3 mm x 3 mm) of 
Celgrade 2500 membrane (Celgrade, Charlotte, NC, USA) with 55% porosity, 25 µm 
thickness and 0.21 µm x 0.05 µm pores previously wetted with 1-octanol was placed on the 
top of buffer drop. The chip was returned to the holder and connected back to the HV supply. 
100 µM umbelliferone and paracetamol samples were prepared in 100 mM HCl. Finally, 8 µL 
of acidic sample solution was added to the top of membrane to initiate extraction. After 
extraction times of 30 s, 60 s or 5 min, injection voltage of +800 V was applied for 6 s and 20 
s, respectively, followed by separation voltage of +1000 V. 
 
3.6 Sample preparation by electrokinetic sample stacking 
 
Electrokinetic sample stacking was performed in SU-8-Pt001T microchip. 100 mM sodium 
borate (pH 10.0) was used as running buffer. Samples of dopamine and paracetamol were 
prepared in 10 mM sodium borate buffer (pH 10.0) To obtain a sample plug inside of the 
separation channel injection was performed from sample inlet "C" to separation outlet "B" 
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("gated" injection). The injection time was approximately half of the migration time for each 
compound. After the "filling" of the separation channel, a voltage of 1000 V was applied from 
separation inlet "A" to separation outlet "B" (normal separation). Detection voltage was + 0.9 
V for dopamine and paracetamol. 
 
3.7 Liquid-liquid extraction 
 
100 µM standards of paracetamol and umbelliferone were prepared in acid environment. The 
total volume of standard was 100 µl. It was composed of 10 µl 2M HCl, MQ-water and stock 
solutions of paracetamol and umbelliferone prepared dissolving solids in 20 mM sodium 
borate buffer pH 10. In Eppendorf tubes with standards, organic solvents DCM, chloroform 
and 1-octanol were added in a 1:1 ratio (100 µl of organic phase), respectively. Each sample 
was mixed using the Vortex machine for 5 minutes and left 5-10 minutes for separation of 
phases. Carefully, using a pipette, phases were separated. After evaporation of the organic 
(solvent) phase, the precipitate was resuspended in 100 µl 20 mM sodium borate buffer pH 10 
and analyzed by MCE-EC. Water phase was kept for extra analysis in case of unsuccessful 
extraction into organic phase.   
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4     Results and discussion 
 
4.1 Choice of buffer 
 
Buffer is one of the most important feature of electrophoresis. The selection of optimal buffer 
requires a few parameters to be considered, such as pKa value that should be close to desired 
pH. In that way a buffer will have the greatest capacity to absorb or release protons. Apart 
from pKa, formal charge of buffer is important feature, same as molecular size. The 
electrophoretic mobility of the counter ion (cation) determinates the magnitude of the 
cathodic electroosmotic flow (EOF).   
In capillary electrophoresis buffer concentration influence electroosmotic flow. EOF is 
reversely proportional to the square root of buffer concentration, therefore, dilute buffers 
provide fastest separation. 
  
In this research, two buffers were used for all studies: MES-NaOH (pH 6.0) and sodium 
borate (pH 10.0). Both buffers showed least interaction with oxidation of analytes, providing 
clear peaks with less background noise. The stabilization of baseline took shorter time with 
sodium borate buffer compared to MES buffer. MES-NaOH required extra runs after every 
washing of microchannel or buffer change. In that way, the use of sodium borate buffer 
shortened analysis time and made it easy to work with.  
 
The influence of buffer concentration on EC signal was studied in this work. Three different 
concentrations of sodium borate buffer were used: 20 mM, 50 mM and 100 mM (pH 10.0). 
Results are shown in the Table 5 and Figure 4.  
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Table 5. Average peak areas, migration times and plate numbers for 100 µM dopamine and 
50 µM paracetamol in different concentration sodium borate buffers pH 10. Conditions: Vsep 
= +1500 V, Vinj = +800 V for 6 s, Ed (dopamine, paracetamol) = +0.9 V. 
 
 20 mM sodium borate 50 mM sodium borate 100 mM sodium borate 
 Area tM [s] N Area tM [s] N Area tM [s] N 
Dopamine 9.46 14.4 634.6 5.99 18.6 1053.9 0.85 21.8 1365.7 
Paracetamol 2.51 16.8 870.2 1.84 22.7 1406.8 0.23 31.7 1582.5 
  
 
As expected, lower concentration buffers provided fastest separation of both paracetamol and 
dopamine (Figure 4). The peak areas became smaller and an increase in plate number was 
noticed for both compounds with an increase of buffer concentration. High concentration of 
buffer molecules interacts with oxidation of species causing decrease in peak area and slower 
migration of analytes towards separation outlet. 
 
 
 
Figure 4. Electropherograms of 50 µM paracetamol (A) and 100 µM dopamine (B) in 20 mM 
sodium borate (i), 50 mM sodium borate (ii), 100 mM sodium borate (iii). Conditions: Vsep = 
+1500 V, Vinj = +800 V for 6 s, Ed (dopamine, paracetamol) = +0.9 V. Leff (effective 
separation length) = 30 mm. 
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The difference between two buffers used in this work was tested on 10 µM dopamine sample. 
Results are given in Figure 5. The longer migration time of compound in sodium borate buffer 
was made the main difference between the two runs. Under optimized conditions there was no 
significant difference in peak shape and peak area. The same peak area for dopamine was 
obtained in both buffers, though the detection potential was optimized separately for each 
buffer and was +0.7 V for MES-NaOH and +0.9 V for Na-borate buffer (Figure 5). 
 
 
 
Figure 5. Electropherograms of dopamine 10 µM in 20 mM MES-NaOH (pH 6.0) (A) and 20 
mM sodium borate (pH 10.0) (B). Conditions: Vinj = +800 V for 6 s, Vsep = +1000 V, Ed (A) = 
+0.7 V, Ed (B) = +0.9 V. Leff = 30 mm. 
 
 
All things considered, the use of low molar concentration (20 mM) both MES and borate 
buffer are acceptable options for drug and metabolite analyses using the MCE-EC device. In 
addition to this, conductivity of dilute buffers is lower, therefore higher electric fields can be 
used.  
If a drug is showing degradation in high pH buffer solution (like diclofenac and its metabolite 
4'-hydroxydiclofenac), lower pH MES buffer should be used as primary option. 
 
4.2 Effect of solvents on obtained signal 
 
The standard solvent for the preparation of stock solutions is dimethyl sulfoxide (DMSO). It 
is a polar, aprotic solvent that dissolves non‐polar and polar compounds and it can be mixed 
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with a wide range of organic solvents and water. If a compound is water-soluble or unstable 
in DMSO, other solvents such as Milli -Q water can be used.  
Dimethyl sulfoxide (DMSO) was the solvent used for the preparation of all stock solutions so 
its electroactivity was studied as a part of this work (Figure 6).  
 
 
 
Figure 6. Electropherograms of paracetamol 100 µM in 20 mM sodium borate (pH 10.0) 
obtained with different detection potentials. Ed = +0.8 V (A), Ed = +1.1 V (B), Ed = +1.3 V 
(C). Conditions: Vinj = 800 V for 6 s, Vsep =1000 V. Leff = 30 mm. 
 
The results indicate that with increase of detection potential above + 1,0 V, the new peak 
starts to appear before the main paracetamol peak. Separation of the same volume of blank 
sample confirmed the peak as DMSO solvent (DMSO: buffer = 1:100). DMSO is visible with 
Ed higher than +1.0 V and it can interfere with detection of other compounds. If the detection 
potential (Ed) of a drug or metabolite in borate buffer exceeds +1.0 V, other solvent should be 
considered as stock preparation solvent.  
One of the methods reported to influence EOF, viscosity, inductivity of separation buffer and 
selectivity of separation is the addition of organic modifiers
29
. The addition of methanol as 
second solvent in buffer solution was studied in this work. New buffers were prepared with 
10% and 30% of methanol, respectively, in 20 mM MES-NaOH buffer (pH 6.0). Results are 
showed in Figure 7. 
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Figure 7. Electropherogram of dopamine 100 µM in 20 mM MES-NaOH with 10 % 
Methanol (A) and 30 % Methanol (B). Other conditions: Vinj = 800 V for 6 s, Vsep = 1000 V, 
Ed = 0.7 V. Leff = 30 mm. 
 
The results indicate that the peak area was decreased with an increase in methanol 
concentration in the buffer. Migration time was increased dramatically, especially with the 
30% concentration of solvent in buffer.  
In conclusion, the addition of methanol did not increase sensitivity, but did lead to a decrease 
of peak height and negatively interfered with detection of dopamine and, therefore, it should 
be avoided as solvent in further MCE-EC tests. 
 
4.3 Assembling the MCE-EC setup 
 
The effect of Micrux microchip holder configuration was studied as there are two possible 
ways of connection mode between HV supply and microchip holder reported by the 
manufacturer. The connection “mode 1”, in which all the inlets (sample “C” and buffer “A”) 
and outlets (sample “D” and buffer “B”) are used, same as three electrodes for detection: 
working, reference and auxiliary electrode. In connection “mode 2”, the auxiliary electrode is 
not used, but its power supply is used as ground “B” or separation outlet. Although there is a 
possibility that non-usage of auxiliary electrode can reduce signal significantly, as well, 
“mode 2” provides faster stabilization of baseline, less baseline noise, thus, clearer peaks in 
almost every run with no significant decrease in peak intensity and area. Therefore, this 
connection configuration was used in this research. 
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The procedure of microfabrication on SU-8 microchips allows obtaining a large number of 
designs. Moreover, the integration of electrodes for amperometric detection during same 
procedure is made possible. In this research three microchip EC detection designs with end-
channel electrode detector were tested. SU-8-Pt001 and SU-8-Pt002 are commercial 
microchips with platinum detector integrated at the end of the separation channel. SU-8-
Au001T is the same design microchip with integrated gold electrodes. Firstly, the difference 
between gold and platinum electrodes was studied using SU-8-Au001T and SU-8-Pt001T 
microchips and dopamine as highly electroactive compound. 20 mM MES-NaOH pH 6.0 was 
employed as a running buffer, a separation voltage of +1000 V and an injection voltage of 
+800 V and +700 V for 4 s, for gold and platinum electrode, respectively.  
The platinum electrode chip provided better results considering the peak area, symmetry and 
migration time (Figure 8). The peak area obtained with platinum electrode microchip was 6,6-
fold larger and a decrease in migration time of about 10 s was noticed. The decrease in 
migration time is most probably a result of differences in microfabrication processes between 
Au and Pt patterning, that have an effect on the final surface properties. 
 
 
 
Figure 8. Electropherograms for 100 µM dopamine in SU-8-Pt001T microchip (A) and SU-8-
Au001T microchip (B). Conditions: running buffer 20 mM MES-NaOH pH=6, Vsep= +1000 
V, Vinj= +800 V for 4 s; Ed= +1.3 V. Leff = 30 mm. 
 
 
The effect of EC electrode geometry was tested using SU-8-Pt001T and SU-8-Pt002T chips 
(Table 6). Dopamine, paracetamol, phenacetin and umbelliferone, 100 µM each, were the 
compounds used in the tests. Sodium borate buffer (20 mM, pH 10.05) was employed as 
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peak areas were 1-1.3-fold bigger using SU-8-Pt002T chip for dopamine, paracetamol and 
phenacetin. Almost a 5-fold increase was observed with umbelliferone sample. However, 
peak symmetry, same as peak height, was better using SU-8-Pt001T chip for two highly 
electroactive compounds dopamine and paracetamol (Figure 9) which is probably due to 
narrower working electrode. On the other hand, wider SU-8-Pt002T working electrode 
provided a larger area. Umbelliferone, however, demonstrated different behavior, better 
shape, a larger area and height, same as big difference in migration time with SU-8-Pt002T 
chip layout.  
 
Table 6. EC electrode geometry effect on peak area, migration times and average plate 
number in 100 µM samples. Conditions: running buffer 20 mM sodium borate pH 10.0; Vsep = 
1000 V, Vinj = 800 V for 6 s. 
 
  SU-8-Pt001T SU-8-Pt002T 
COMPOUND Ed [V] 
Average 
peak area 
tM [s] 
Average 
N 
Average 
peak area 
tM [s] 
Average 
N 
Dopamine 0.9 17.96 26 1179.75 19.17 22 428.05 
Paracetamol 0.7 8.30 28 1541.26 10.933 25 811.4 
Phenacetin 1.3 26.22 25 541.82 32.715 22 368.63 
Umbelliferone 1.0 1.205 66 2701.23 5.827 47 2256.55 
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Figure 9. Electropherograms of dopamine 100 µM in SU-8-Pt001T (A) and SU-8-Pt002T (B) 
and paracetamol 100 µM in SU-8-Pt001T (C) and SU-8-Pt002T (D). Leff = 30 mm. 
 
As expected, better sensitivity is achieved with narrower platinum working electrode, hence 
the choice of SU-8-Pt001T electrode microchip for detection of low drug concentrations. 
 
MicruX Manager software, besides controlling electrophoresis processes, offers the 
possibility of reducing baseline noise by changing filter parameters. It is possible to change 
frequency and order parameters to obtain the best signal for each compound. To obtain their 
effect on signal, a few different frequency and order values were tested. The study has 
indicated no significant difference between frequencies from 1 to 100. At the frequency of 0.1 
the peak area was 2-fold lower, wider on the baseline and the background noise was reduced 
to minimum. A frequency lower than 1 provides more filtering, but causes filtering and 
reduction of the main signal. For further research the frequency 5 was chosen with order value 
1. The increase in order value was tested with same 50 µM paracetamol sample under same 
conditions. The results showed a spreading of peaks on the baseline with an increase in order 
parameter. For further studies order value 1 was used. In all runs showed on Figure 10 the 
order value was set to 1 and the frequency value was changed. 
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Figure 10. Electropherogram of 50 µM paracetamol in 20 mM sodium borate as running 
buffer. Testing filter parameters was performed with Vsep = +1500 V, Vinj = 800 V for 6 s. Leff 
= 30 mm. In all runs showed on graph order value was set to 1 and frequency value was 
changed. 
 
4.4 Analytical method development 
 
A successful application of microchip electrophoresis (MCE) with electrochemical 
(amperometric) detection for metabolic assays requires finding optimal parameters such as 
injection time and voltage. Sample injection, in this case, was electrokinetic, which means 
that a sample is injected by applying a voltage to sample inlet. A schematic view is shown on 
Figure 2, where voltage is applied to inlet "C", and outlet "D" was used as ground, zero 
voltage site. The injected volume depends on electroosmotic flow (EOF), electrophoretic 
mobility of molecules and temperature.  
In this research, different injection times and voltages were tested and the results are shown in 
Figure 11. 20 mM MES-NaOH buffer was applied as running buffer and 100 µM dopamine 
was used as the test compound. 
As shown in Figure 11, applying higher voltages and injection times results in an increase of 
peak area as a result of bigger volume in channels intersection. After a certain point, a 
broadening of dopamine peak was observed. Applying too high of a voltage resulted in great 
peak area but also in loss of symmetry. It was necessary to compromise conditions in order to 
get best performance. Shorter injection times of 4, 5 and 6 seconds with the injection voltage 
of 700 to 900 V/cm were the best choice for most of the compounds. 
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Figure 11. Electropherograms of dopamine 100 µM in 20 mM MES-NaOH pH 6.0.  
Effect of injection time on signal shape: 4 seconds (A), 7 seconds (B) and 10 seconds (C), Vinj 
= +750 V; and effect of injection voltage on peak shape: +250 V (D), +500 V (E), +700 V (F) 
and 1000 V (G); injection time 4 s. Other conditions Vsep = +1000 V, Ed = +1.3 V. Leff = 30 
mm. 
 
Linear dynamic range was established for dopamine, paracetamol and umbelliferone and 
given in Figure 12. Due to fast degradation of 4-hydroxydiclofenac its dynamic range was 
excluded from results. 
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Figure 12. Linear dynamic ranges for dopamine, paracetamol and umbelliferone in 20 mM 
sodium borate pH 10.0. Microchip: SU-8-Pt001T. Conditions (dopamine): Vsep = +1000 V, 
Vinj = +800 V for 6 s, Ed = +0.9 V; conditions (paracetamol): Vsep = +1000 V, Vinj = +800 V 
for 6 s, Ed = +0.8 V; conditions (umbelliferone): Vsep = +1000 V, Vinj = +800 V for 6 s, Ed = 
+0.8 V. Leff = 30 mm. 
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The limit of detection (LOD) and the limit of quantification (LOQ) are important validation 
characteristics used to describe the lowest concentration of an analyte that can be detected and 
measured in the analytical process. There are a few common methods for determining the 
LOD and LOQ
30
. In this assay, the calculation from calibration curve at low concentrations
31
 
was used as a method. Commercial SU-8-Pt001T chip was used in all of the tests. Dopamine 
was chosen as test electroactive compound. LOD and LOQ for dopamine, paracetamol, 
umbelliferone and 4'-hydroxydiclofenac were estimated in 20 mM sodium borate buffer pH 
10.0 and 20 mM MES-NaOH buffer pH 6.0, respectively (Table 7). 
 
Table 7. LOD and LOQ values for tested compounds in different buffers  
 
 20 mM sodium borate pH 10.0 20 mM MES-NaOH pH 6.0 
COMPOUND LOD [µM] LOQ [µM] LOD [µM] LOQ [µM] 
Dopamine 1.67 5.07 0.92 2.77 
Paracetamol 0.64 1.94 n/a n/a 
Umbelliferone 3.03 9.18 n/a n/a 
4'-OH-diclofenac 5.37 16.29 n/a n/a 
 
 
For all the compound tested with MCE-EC method, a low micromolar concentration could be 
detected which is the base point for the application of this method to drug inhibition 
screening.  
Dynamic ranges of paracetamol, dopamine and umbelliferone exceed ranges 0.302-0.232 
µg/ml, 0.766-22.977 µg/ml and 1.492-32.428 µg/ml, respectively. The method is suitable for 
in vitro screening of metabolites, and linearity ranges are follow the ranges reported by 
conventional analytical methods such as tandem GC-MS and HPLC
32
.  
 
However, sample enrichment and purification method (preferably implemented on-chip) are 
needed in addition to the MCE-EC method to increase its sensitivity and improve peak shape 
and height. Some of them are tested and reported in this work. 
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4.5 On-chip sample preparation experiments 
 
4.5.1 Liquid phase microextraction 
 
Liquid phase microextraction (LPME) under totally stagnant conditions and combined with 
MCE was reported for the first time in 2009 as an on-line sample preparation method
33
. The 
main principle is extraction of analytes from acidic, aqueous sample droplet through porous 
membrane wetted with organic phase, into basic, aqueous acceptor solution (buffer). pH of 
donor solution was adjusted to 1-2 by preparing samples in 100 mM HCl. pH of acceptor 
solution (buffer in sample inlet) was 10. Both pH values were adjusted in the way to ensure 
that paracetamol and umbelliferone are in neutral form in the sample droplet, which allows 
them to pass organic phase in membrane, and fully protonated in acceptor solution. The 
ionization of analytes in acceptor solution should prevent them from reentering the organic 
phase membrane.  
For both compounds tested with different extraction times (from 30 seconds to 5 minutes) and 
different injection times (from 6 s to 20 s) there was no analyte peak. Applying the sample 
directly under the membrane produced a peak after injection of 6 seconds and separation with 
+1000 V, which confirmed that the problem is not in the injection and electrophoresis 
process, but in the extraction of the compound through the membrane. The extraction could 
be completely unsuccessful or very slow, which causes most of the compounds to stay close 
to the membrane and diffuse very slowly to the channel inlet.  
 
4.5.2 Electrokinetic sample stacking 
 
Electrokinetic sample stacking was developed as an enrichment method in this work and it is 
based on the difference in electric field strength (and conductivity) between sample zone and 
separation zone. The samples are prepared in 10-fold lower concentration buffer and therefore 
a sample zone has low conductivity and high electric field strength. As a separation buffer, 
10-fold higher concentration buffer (higher conductivity and lower electric field strength) was 
employed. Analyte migrates faster in sample region (sample plug) and moves to the boundary 
between sample and separation buffer which results in narrowing of the analyte zone. A 
compound will have higher concentration than the original concentration in the sample 
(Figure 13). 
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Figure 13. Schematic view of electrokinetic sample stacking. After "gated" injection, sample 
plug is formed inside capillary (A). Analytes migrates faster in high electric field (sample) 
region forming narrow analyte zone (B).  
 
Electrokinetic sample stacking was developed for dopamine and paracetamol (Figure 14 and 
Figure 15). 
 
 
Figure 14. Electropherogram of dopamine 100 µM obtained after preconcentration of sample 
prepared in 10 mM sodium borate buffer pH 10.0 with 100 mM sodium borate pH 10.0 
employed as running buffer (A). Conditions: Vsep = +1000 V, Vinj ("gated" injection C → B) 
= +800 V for 15 s, Ed = +0.9 V; and electropherogram of "normal" injection of same 
concentration dopamine with 100 mM sodium borate pH 10.0 as running buffer (B). 
Conditions: Vsep = +1500 V, Vinj ("floating" injection C → D) = +800 V for 6 s, Ed = +0.9 V. 
Leff = 30 mm. 
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In the case of the dopamine, the electropherogram showed two separated peaks after 
performing the electrokinetic sample stacking. The first peak was concluded to originate from 
neutral dopamine and the second from negatively charged dopamine. pKa value of dopamine 
is close to 10 (pH of buffer used in run) which resulted in neutral charge of some of the 
dopamine molecules in the sample. The use of pH higher than 10 resulted in fast degradation 
of dopamine sample in buffer and whole dopamine could not be transformed to charged 
species.  
Paracetamol (pKa = 9.5) electrokinetic sample stacking enrichment is shown in Figure 15. All 
molecules are negatively charged and collected in one narrow zone which resulted in about 8-
fold bigger peak area compared to run in 100 mM buffer under same conditions. 
 
 
 
Figure 15. Electropherograms of paracetamol 50 µM with electrokinetic sample stacking with 
10 mM sodium borate pH 10.0 as a sample buffer and 100 mM sodium borate as running 
buffer (A); and paracetamol 50 µM without sample stacking with 100 mM sodium borate pH 
10.0 as running buffer (B). Other conditions: Vsep = +1000 V, Vinj (A) 800 V for 24 s (gated C 
→ B injection); Vinj (B) +800 V for 6 s (C → D injection), Ed = +0.9 V. Leff = 30 mm. 
 
Electrokinetic sample stacking proved to be fast and practical on-chip method which has 
increased peak area multiple times, thus it is feasible for use in combination with this 
technique.  
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4.6 Liquid-liquid extraction (off-chip sample purification) 
 
In vitro metabolism assays are performed by using liver microsome fractions from humans or 
experimental animals. Using human liver microsomes as in vitro systems allows evaluation of 
the main phase I metabolites formed by cytochrome P450. They are a useful tool for 
determination of metabolic pathways, as well of possible inhibitions of CYP enzymes by 
commonly used drugs or different environmental chemicals. The motivation for this work is 
the validation of MCE-EC as a screening method for metabolic assays performed on in vitro 
human liver microsomes. Except for the successful separation of drugs from metabolites 
formed in incubation process, the main goal is their separation from electroactive compounds 
inside the incubation matrix. For this reason, liquid-liquid phase extraction (LLE) was tested 
as a sample purification method.  
 
LLE is a method based on solubility of compounds in two different liquid phases, water and 
organic phase. By acidifying the standard sample, paracetamol and umbelliferone were in 
neutral form which allowed them to transfer into organic phase and separate from extra 
electroactive compounds from matrix left in water phase. Redissolution of the precipitate after 
evaporation of organic phase was the most important step of extraction. The sample tested 
immediately after redissolution was negative for analytes (Table 8). After one day and extra 
mixing, same samples were positive for paracetamol and umbelliferone (Figure 16).  
 
Table 8. List of solvents used in LLE with compounds and their peak areas after extraction 
and MCE analysis. Peak areas were obtained after 24 hour of redissolution.  
 
 PEAK AREA 
 PARACETAMOL UMBELLIFERONE 
CLOROFORM 2.35 n/a 
Dichloromethane (DCM) 3.094 3.71 
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Figure 16. Electropherograms after redissolution of residue left after evaporation of organic 
phase. Paracetamol after LLE and evaporation of chloroform (A), paracetamol after LLE and 
evaporation of DCM (B). Conditions: Vsep = +1500 V, Vinj = +800 V for 6 s, Ed = + 1.1 V. 
Buffer: 20 mM sodium borate pH 10.0. Leff = 30 mm. 
 
4.7 Microchip electrophoresis separations 
 
MCE-EC platform was tested as a practical and fast screening platform for some CYP P450 
substrates and metabolites. To determine the feasibility of method for environmental purposes 
mentioned in the introduction, substrates and metabolites needed to be separated on the 
baseline from each other. For that purpose, long channel microchips were used. Electrode 
geometry of microchips is the same as in SU-8-Pt001T.  
 
To determine if the method can be used for in vitro metabolism assays, substrate and 
metabolite have to be sufficiently resolved from each other during the CE separation and 
detected in concentration needed for Michaelis-Menten kinetics.  
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CYP1A2 - Km ≈ 1-116 µM 
CYP2A6 - Km ≈ 0.3-2.4 µM 
CYP 2C9 - Km ≈ 3.1-13 µM 
 
In Michaelis-Menten kinetics, the substrate concentration is very much larger than the 
concentration of a product. With this in mind, the detection of metabolites is a challenge when 
it comes to this method. Paracetamol concentration produced in enzyme incubations is 1-5 
µM and umbelliferone concentration is 0.1-10 µM.  
Both phenacetin/paracetamol and coumarin/umbelliferone pairs were separated successfully 
in 20 mM borate buffer (pH 10.0), using the highest separation voltage possible with Micrux 
platform, i.e., at +3000 V, which gave approximately 545 V/cm. The results showed that 100 
µM substrate and 20 µM metabolite concentration could be easily separated and detected with 
custom long channel microchip in both cases, coumarin/umbelliferone and 
phenacetin/paracetamol (Figure 17). The lower concentration of analytes, 50 µM substrate 
and 10 µM metabolite, were tested after that. Phenacetin and paracetamol could be separated 
and detected in lower concentration (Figure 17. C), but in case of coumarin/umbelliferone 
metabolite the peak was not visible anymore.  
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Figure 17. Separation of substrates and metabolites. Running buffer 20 mM sodium borate 
(pH 10.0). Separation voltage +3000 V (545 V/s). Detection potential: +1,1 V (A), +0.9 V 
(B), +1.0 V (C). Leff = 50 mm. 
 
Altogether, the separation and detection of phenacetin and paracetamol is successful and it 
could be performed even without any sample enrichment protocol. Coumarin and 
umbelliferone are successfully separated, but the detection of umbelliferone in such low 
concentration requires an extra enrichment technique.    
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4.8 Dissolution assays with indomethacin 
 
Apart from finding the optimal conditions for determination of CYP P450 substrates and 
metabolites, a technique was tested as a potential method for the examination of very poor 
soluble drugs, such as indomethacin. Indomethacin was tested in bulk form, firstly dissolved 
in DMSO as 10 mM stock solution, then prepared in 20 mM sodium borate buffer (pH 10.0) 
in a certain concentration. Afterwards, it was tested in nanoparticle formulation, prepared with 
Poloxamer 407 (Lutrol F127) using milling technique.  
Results indicated a weak signal of indomethacin in bulk form with Ed from 0,7 to 0,9 V which 
was confirmation of indomethacin electroactivity and first step in dissolution assays. 
Indomethacin nanoparticle formulation was tested in the same way, by dissolving in 20 mM 
sodium borate (pH 10.0). Nanoparticles are prepared in order to increase solubility of 
indomethacin and in contact with borate buffer all nanoparticles were quickly dissolved.  The 
analysis of nanoparticle sample with same detection potential gave a negative peak with 
different migration time in every run. This unusual outcome could be a result of the 
interference of polymer and indomethacin in nanoparticle form of drug. Polymer alone was 
also analyzed (in same concentration as in nanoparticle formulation) and results showed no 
peak at Ed from 0.7 to 0.9 V.  
Because of the interference and impossibility of analyte detection inside nanoparticles, 
conclusion can be made that this method is not feasible for this type of dissolution assays. 
Nevertheless, dissolution assays in combination with MCE-EC represent an interesting topic 
and further research in this direction can yield more promising results. 
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5     Conclusions 
 
The aim of this research was to examine the feasibility of MCE-EC platform for metabolism 
assays using CYP probe reactions, together with optimizing conditions and parameters for 
metabolism and enzyme inhibition studies. Firstly, MCE-EC technique proved to be a very 
practical and fast screening method following the µTAS ("lab-on-chip") concept. It requires 
very small volumes for analyses of low concentrations of drugs and their metabolites. For all 
of tested compounds, paracetamol, umbelliferone and 4'-hydroxydiclofenac, low micromolar 
concentrations could be detected with MicruX platform which, together with successful 
separation of drug and metabolite pairs, forms basis for metabolism assays.  
 
Limits of detection and quantification for all the compounds were reached in low micromolar 
concentrations. To obtain even lower LOD and LOQ values, a few sample enrichment 
methods were tested. Electrokinetic sample stacking proved to be a useful method for 
increasing detection sensitivity and it can be easily applied on MCE-EC instrument used. 
LPME (liquid phase microextraction), on the other hand, turned out to be an unsuccessful 
sample enrichment method, so one of the challenge still remains in finding an "on-line" 
sample preparation protocol which can be implemented directly on the platform.  
 
Metabolism assays with CYP probe reactions are imitating physiological conditions and they 
should be performed in biological matrix, which leads to another challenge of detecting 
metabolites in mixture of many electroactive compounds. Liquid - liquid extraction was tested 
as simple purification method for that purpose and proved to be successful a answer to the 
extraction of metabolites from incubation matrix. The extraction still needs to be combined 
with an enrichment method in order to obtain a clear and strong signal of metabolites, which 
remains a challenge for further MCE-EC research.  
 
Enzyme reactions are initiated by adding a high concentration of cofactors like NADPH into 
drug-matrix probe and stopped by adding inhibitors such as furafylline (CYP1A2 inhibitor).  
The interference of both was tested as a part of this research. The NADPH did not give a 
signal with all detection potentials which leads us to conclude that this cofactor is not an 
electroactive compound. Same as NADPH, inhibitor furafylline did not interfere with 
detection of any of analytes. From these results, a conclusion can be drawn that this kind of 
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electrophoresis instrument with electrochemical detection is feasible for in vitro metabolism 
assays. 
 
Apart from metabolism assays, MicruX instrument appears to be a very practical, fast and 
handy device for any kind of analysis that requires higher sensitivity. Apart from that, it has 
shownd to be a good tool for learning about electrophoresis on microchip in an easy way, 
providing a wide range of possibilities, such as implementation of different ideas directly on 
platform, the use of microchips of different geometries and materials, and manipulation with 
voltages, currents and many more.  
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7     Summary 
 
In a period of rapidly growing pharmaceutical industry development of the current analytical 
techniques is by far too slow to fulfill requests of demanding metabolic analysis of new 
pharmaceuticals and new chemical entities (environmental and household chemicals).  
 
Portable Microchip Capillary Electrophoresis (MCE) platform with amperometric 
electrochemical detection (EC) was developed in this work, offering a new approach to 
analytical chemistry. By following Micro Total Analysis System (µTAS) concept, MCE-EC 
platform combines rapid analysis, low price and practicality with low requirements of 
reagents.  
 
Research was made by using compact platform for MCE-EC purchased from MicruX 
Techologies. It was developed for chosen drug/metabolite pairs (phenacetin/paracetamol, 
coumarin/umbelliferone and diclofenac/4'-hydroxydiclofenac). Different voltages, analysis 
times and system setups were tested. In addition to this, different on-chip sample preparation 
and purification methods (liquid phase microextraction and electrokinetic sample stacking) 
were implemented on this easy-handle platform. The linearity of an analytical procedure, as 
well as the limit of detection (LOD) and the limit of quantification (LOQ) were determined.  
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8     Sažetak 
 
UVOD 
Nalazimo se u razdoblju ubrzanog rasta istraživačkog područja farmaceutske industrije. U 
dugotrajnim pretkliničkim istraživanjima novih kemijskih entiteta najveći izazov još uvijek 
ostaje određivanje metaboličkih reakcija, inhibicije i indukcije metaboličkih enzima i 
interakcija s ostalim ksenobioticima. Osim lijekovima, ljudi su konstantno izloženi raznim 
kemikalijama iz okoliša i kućanstva. I dok su učinci lijekova uglavnom poznati, fiziološki 
učinci ostalih kemikalija su vrlo malo istraživani. Kapilarna elektroforeza implementirana na 
mikročip (MCE) te niska cijena, kompatibilnost s mikrofabrikacijom i visoka osjetljivost 
elektrokemijske detekcije (EC) su donijeli novi pristup u području analitike lijekova i 
ksenobiotika. 
 
OBRAZLOŽENJE TEME 
Svrha rada je razvoj metode elektroforeze na mikročipu s elektrokemijskom detekcijom u 
svrhu brzih analiza izabranih CYP 450 supstrata i metabolita (fenacetin/paracetamol, 
kumarin/umbeliferon, diklofenak/4-hidroksidiklofenak). Na taj način omogućilo bi se brzo i 
olakšano analiziranje metabolizma lijekova i ksenobiotika u kombinaciji s in vitro testovima. 
 
MATERIJALI I METODE 
 
Matične otopine pripremljene su vaganjem krutina (fenacetina, paracetamola, umbeliferona, 
kumarina, diklofenaka i 4-hidroksidiklofenaka) i otapanjem u dimetilsulfoksidu (DMSO). 
Boratni i MES pufer pripremljeni su vaganjem krute borne kiseline i MES hidrata, otapanjem 
u deioniziranoj (MQ) vodi. pH je podešen korištenjem 2 M NaOH. 
Prijenosni i kompaktni analitički instrument nabavljen je od tvrtke MicruX Technologies 
(Oviedo, Španjolska), a rad mu se temelji na elektroforezi na mikročipu s elektrokemijskom 
detekcijom. Kao mikročipovi korišteni su SU-8/staklo čipovi od istog proizvođača. Tanke 
film elektrode smještene su na kraju separacijskog kanala, a dimanzije mikrokanala su 20 x 
50 µm s jednostavnom "križnom" geometrijom.  
 
REZULTATI I RASPRAVA 
Izbor otopine pufera 
U ovom radu dvije otopine pufera su korištena za sva ispitivanja: MES-NaOH (pH 6.0) i 
boratni pufer (pH 10.0). Utjecaj koncentracije pufera na elektrokemijski signal ispitan je 
korištenjem tri različite koncentracije boratnog pufera 20 mM, 50 mM i 100 mM. Prema 
očekivanju, niža koncentracija pufera rezultirala je kraćim migracijskim vremenom. Površina 
pika smanjivala se s povećanjem koncentracije pufera. Razlika između dva korištena pufera 
ispitana je na uzorku dopamina. Duže migracijsko vrijeme (oko 10 s) zabilježeno je 
korištenjem boratnog pufera. Uz optimizaciju uvjeta nije bilo značajnih razlika između dva 
pufera te su oba kompatibilna za korištenje u analizi lijekova i metabolita. 
 
Utjecaj otapala na dobiveni signal 
Dimetilsulfoksid (DMSO) je standardno otapalo za pripremu matičnih otopina pa je ispitana 
njegova elektroaktivnost. Rezultat je pokazao kako s povećanjem detekcijskog potencijala 
iznad +1.0 V dolazi do nastajanja pika koji je potvrđen kao DMSO dodatnim analizama te 
može negativno interferirati s detekcijom drugih spojeva. Dodatak metanola kao drugog 
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otapala u otopinu pufera je također ispitan. Novi puferi su pripremljeni s 10% i s 30% 
metanola. Rezultat pokazuje značajno produljenje migracijskog vremena, smanjenje površine 
pika te zbog svega navedenog metanol treba izbjegavati u daljnjim ispitivanjima s MCE-EC 
tehnikom. 
Podešavanje postavki instrumenta 
Razlike između čipova sa zlatnim i platinastima elektrodama utvrđene su korištenjem SU-8-
Au001T i SU-8-Pt001T mikročipova analizom dopamina. Platinasta elektroda pokazala je 
bolje rezultate uzimajući u obzir površinu pika, simetriju pika i migracijsko vrijeme. Osim 
toga, ispitan je i utjecaj geometrije elektrode na signal. Šira radna elektroda na SU-8-Pt002T 
čipu dala je veću površinu pika, ali je uska radna elektroda SU-8-Pt001T, očekivano, 
rezultirala s boljom simetrijom i visinom dobivenih pikova.  
 
Razvoj analitičke metode 
Kao dio istraživanja i razvoja metode ispitani su različiti naponi i vremena injektiranja 
uzorka. Primjena visokih napona te duljih vremena injektiranja rezultira s većim površinama 
dobivenih pikova zbog većeg volumena uzorka u području križanja mikrokanala. Kraća 
vremena injektiranja (4-6 s) s naponima 700-900 V/cm izabrani su kao optimalni uvjeti. 
Područja linearnosti za paracetamol, dopamin i umbeliferon su redom 0.302-0.232 µg/ml, 
0.766-22.977 µg/ml i 1.492-32.428 µg/ml. Limiti detekcije (LOD) i limiti kvantifikacije 
(LOQ) u boratnom puferu su 0.64 i 5.07 µM za paracetamol, 1.67 i 5.07 µM za dopamin, 3.03 
i 9.18 µM za umbeliferon te 5.37 i 16.29 µM za 4-hidroksidiklofenak.  
 
Metode pripreme uzorka 
Mikroekstrakcija na tekućoj fazi je implementirana na MCE platformu, ali nije pokazala 
uspješan rezultat. Metoda nije rezultirala pikom zbog  neuspješne ili vrlo spore ekstrakcije 
analita kroz polupropusnu membranu zbog čega molekule ispitivane tvari nisu difundirale do 
otvora mikrokanala. 
Elektrokinetičko slaganje uzorka, s druge strane, je metoda koja je uspješno primijenjena jer 
je uočeno višestruko povećanje površine pikova dopamina i paracetamola. 
Ekstrakcija tekuće-tekuće se pokazala kao uspješna metoda za pročišćavanje uzorka iz 
inkubacijskog matriksa korištenih za in vitro metaboličke reakcije.  
 
Razdvajanje lijekova i metabolita elektroforezom na mikročipu 
Oba para lijek/metabolit, fenacetin/paracetamol i kumarin/umbeliferon uspješno su razdvojeni 
korištenjem navedene metode u kombinaciji s modificiranim SU-8-Pt001T mikročipom s 
dugim separacijskim kanalom. Uspješno razdvajanje ovih parova temelj je korištenja MCE-
EC metode u svrhu brzih, metaboličkih in vitro analiza. 
 
ZAKLJUČAK 
Metoda koja koristi MCE-EC instrument, razvijana u ovom istraživanju, pokazala je dobre 
rezultate u analizi lijekova i metabolita. Niske koncentracije metabolita uspješno su 
detektirane nakon optimizacije svih parametara, a metaboliti su razdvojeni od lijekova na 
baznoj liniji. Međutim, izazov ostaje u pronalasku  metode za pročišćavanje i 
ukoncentriravanje uzorka, po mogućnosti implementirane direktno na mikročip, kako bi se 
zadržala koncepcija mikro sustava za kompletnu analizu (µTAS). 
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